Liver Transplant DisorderNPBCNCT06658665
Nomogram for Predicting Biliary Complication
An observational study of Liver Transplant Disorder, run by Sun Yat-sen University.
Trial summary
The goal of this observational study is to develop a nomogram model to predict biliary complications within 90 days in adult patients after liver transplantation. The main questions it aims to answer are: Can the nomogram predict biliary complications within 90 days in adult patients after liver transplantation? What… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Liver Transplant Disorder
- How many people
- 900 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2024to 30 Dec 2024
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Retrospective collection of cases of patients who underwent liver transplantation in the Organ Transplantation Department at Sun Yat-sen University First Affiliated Hospital between January 1, 2016, and December 31, 2021.
Who may be able to join
- ①Patients aged ≥ 18 years.
- ②Patients who underwent their first liver transplantation at Sun Yat-sen University First Affiliated Hospital between January 1, 2016, and December 31, 2021.
Who cannot join
- Living donor liver transplantation. ② Split liver transplantation.
- Multi-organ transplantation. ④ Missing preoperative baseline indicators and postoperative ultrasound examination results.
- Patients undergoing re-transplantation.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Nomogram for Predicting Postoperative Early Biliary Complication in Adult Patients Following Liver Transplantation: a Retrospective Study
The goal of this observational study is to develop a nomogram model to predict biliary complications within 90 days in adult patients after liver transplantation. The main questions it aims to answer are:
Can the nomogram predict biliary complications within 90 days in adult patients after liver transplantation? What about the performance of the nomogram? Researchers will compare patients' preoperative variables, intraoperative factors, and postoperative outcomes to see what factors are associated with biliary complications.Subsequently, multivariable logistic regression analysis was conducted to evaluate the factors associated with biliary complications occurring within 90 days post-liver transplantation. Finally, a nomogram was developed.
Read the detailed description
Background: Liver transplantation (LT) is a critical therapeutic intervention for patients with end-stage liver disease or acute liver failure, offering favorable outcomes with survival rates of 76-90% at 1 year and approximately 70% at 5 years . Despite significant advancements in surgical techniques, immunosuppressive protocols, and organ preservation, biliary complications (BCs) remain a substantial cause of morbidity and mortality, frequently necessitating long-term interventions such as endoscopic, percutaneous, or surgical procedures. The incidence of BCs post-LT is estimated to range from 5% to 20%, with most occurring within the first three months postoperatively, although some may present years after LT . Among BCs, the most common are anastomotic strictures (AS), non-anastomotic strictures (NAS), and bile leaks. Treatment approaches include endoscopic techniques, percutaneous transhepatic biliary drainage, and surgical interventions. NAS and bile leaks typically manifest within the first year post-transplant but may arise later, with bile leaks occurring immediately or within weeks following surgery . Early postoperative monitoring and timely management are essential to preventing and addressing these complications.
In adult liver transplantation, several factors contribute to bile duct complications, including biliary ischemia, surgical techniques, infections, and donor characteristics . Among these, insufficient arterial blood supply to the bile ducts is recognized as a key factor likely contributing to the development of biliary complications. Unlike the liver parenchyma, which receives blood from both the portal vein and hepatic artery, the bile ducts depend solely on arterial blood flow. About 60% of the common bile duct's blood comes from the gastroduodenal artery, with the remaining 30-40% from hepatic artery branches. After liver transplantation, blood flow from the gastroduodenal artery is often disrupted, making the hepatic artery's role in supplying the distal bile duct even more critical. This reduced arterial support highlights the significance of maintaining adequate hepatic artery perfusion to prevent bile duct complications.
Ultrasound is essential for monitoring post-liver transplantation biliary complications, providing detailed imaging for early detection of issues like strictures and leaks. Parameters such as arterial resistive index (ARI) and flow velocity are critical for assessing hepatic artery condition and blood supply post-transplantation, offering insights into graft perfusion and viability. These non-invasive metrics are crucial for evaluating hepatic arterial circulation, may provide effective postoperative care and improving patient outcomes.
After liver transplantation, biliary complications most commonly occur during the early postoperative period, particularly within the first three months. More than half of all biliary complications are early complications occurring at the anastomotic site. Hence, early monitoring and intervention are crucial to promptly detect and manage these potential complications, thereby improving patient prognosis and survival rates in clinical settings. However, there is limited research on the risk factors and predict model for 90 days biliary complications after adult liver transplantation. Nomogram is a simple visual graph of statistical prediction model with an easy-to-use graphical interface. Importantly, it could generate personalized predictions, thereby, widely used in risk stratification and personally providing approach to disease management. This study aimed to establish a nomogram model to evaluate patients who underwent LT to help clinicians predict the risk of 90 days biliary complications and provide a more personalized treatment strategy.
Method Patients Data from patients who underwent OLT between 1 January 2016 to 31 December 2021 at the First Affiliated Hospital of Sun Yat-sen University were retrospectively extracted from the electronic medical record system. Exclusion criteria included age <18 years old, multiple organ transplantation, retransplantation, died intraoperatively or within 3 months after LT, and cases with missing important data or over 20% of data missing. Finally, a total of 757 patients were enrolled. This research study was reviewed and approved by the Ethics Committee at Hospital, waiving the requirement for informed consent in alignment with the Declaration of Helsinki. All operations were performed in accordance with the standard procedures by experienced surgical groups in our department.
Study protocol The work was approved by the Ethics Committee and registered on Clinicaltrial.gov. It was conducted and reported in line with the strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) criteria.
Difinition of biliary complications Biliary complications were suspected when patients exhibited fever, jaundice, or pale stools, or when lab results showed elevated conjugated bilirubin, gamma-glutamyltransferase, or alanine aminotransferase, with or without intrahepatic duct dilation on ultrasound. The diagnosis was primarily based on ultrasound findings and confirmed through Magnetic Resonance Cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP). Anastomotic strictures were defined as those within 1 cm of the surgical anastomosis, while non-anastomotic strictures were located at least 1 cm beyond it. Bile leakage was defined as the unintended escape of bile, confirmed by contrast extravasation during MRCP or ERCP.
Data collection and potential predictors Preoperative recipient variables included sex, age, height, weight, BMI, comorbidities (hypertension or diabetes mellitus), etiology of liver disease (viral hepatitis, malignancy, hepatic failure, cirrhosis, alcohol-related liver disease, and others), MELD score, Child-Pugh grade, and preoperative lab values (routine blood tests, coagulation markers, electrolytes, and biochemistry). Donor variables included sex, age, height, weight, BMI, type of donation, HBV infection status, and preoperative lab results. Intraoperative factors involved surgical technique , and specific biliary events (choledochojejunostomy or biliary stenting). Postoperative outcomes included arterial resistive index within 24 hours, transaminase levels, International Normalized Ratio, and ICU stay duration.
Logistic regression analysis and nomogram model development A total of 757 patients were randomly allocated into training and validation sets in a 7:3 ratio. To identify potential predictive factors, LASSO regression analysis was applied to the training set. This method effectively removed several irrelevant and multicollinear independent variables, thereby simplifying the high-dimensional data[. Subsequently, multivariable logistic regression analysis was conducted to evaluate the factors associated with biliary complications occurring within 90 days post-liver transplantation. Finally, a nomogram was developed from the training set and validated using the validation set.
Apparent performance of the nomogram Discrimination and calibration were utilized to evaluate the predictive accuracy of the developed model. Harrell's concordance index (C-index) and the receiver operating characteristic (ROC) curve (AUC) were calculated to assess the nomogram's discrimination capability. A C-index approaching 1 suggests a strong predictive ability of the model, while an AUC exceeding 0.80 indicates good discrimination. Furthermore, decision curve analysis (DCA) was conducted to examine the clinical applicability of the nomograms [Reporting and interpreting decision curve analysis: a guide for investigators.]. Both discrimination and calibration were evaluated using bootstrapping with 1000 resamples.
Statistical analysis: Continuous variables were not normally distributed according to the Kolmogorov-Smirnov test and were therefore analyzed using the Mann-Whitney U-test and presented as median (interquartile range). Categorical variables were compared using the χ2-test or Fisher's exact test and presented as absolute numbers (percentage). Statistical analysis was performed using R Software v.4.0.2 (The R Project for Statistical Computing, www.r-project. org) with the 'rms' package utilized for logistic regression analysis and nomogram construction. A two-sided P-value less than 0.05 was considered statistically significant.
- Conditions
- Liver Transplant Disorder
- Keywords
- liver transplantation, biliary complication, nomogram, prediction model
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| No biliary complication group | The liver transplant patients who did not experience biliary complications within 90 days post-operation. | |
| biliary complication group | The liver transplant patients who experience biliary complications within 90 days post-operation. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Mass Index (BMI):
Calculated as weight (kg) / height (m²).
Measured: 1-2 days before surgery
Surgical Technique
Type of technique used (orthotopic, piggyback, or ischemia-free liver transplantation).
Measured: Intraoperative time
Weight
Measured in kilograms.
Measured: 1-2 days before surgery
Height
Measured in meters.
Measured: 1-2 days before surgery
Blood Loss
Measured in milliliters (mL).
Measured: 1-2 days before surgery
Cold Ischemic Time
Measured in minutes.
Measured: intraoperative time
Warm Ischemic Time
Measured in minutes.
Measured: intraoperative time
Secondary outcomes (2)
Transaminase Levels
Measured in units per liter (U/L)
Measured: 24 hours post-surgery.
ICU Stay Duration
Measured in hours.
Measured: 24 hours post-surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2024
- Study start1 Nov 2024 (estimated)
- Primary completion15 Nov 2024 (estimated)
- Study completion30 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Liver Transplant DisorderStudies of the same condition, open and under way.
- More trials run by Sun Yat-sen UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 900 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sun Yat-sen University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zepeng lin, Sun Yat-sen University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06658665
- Sponsor's protocol ID
- FAH-SYSU
- Acronym
- NPBC
- Status last verified
- Oct 2024
- First submitted
- 23 Oct 2024
- Last updated
- 26 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The data sets used and/or analyzed for the present study are available from the corresponding author on reasonable request.
Publications
Tingle SJ, Thompson ER, Ali SS, Figueiredo R, Hudson M, Sen G, White SA, Manas DM, Wilson CH. Risk factors and impact of early anastomotic biliary complications after liver transplantation: UK registry analysis. BJS Open. 2021 Mar 5;5(2):zrab019. doi: 10.1093/bjsopen/zrab019.
PubMed 33855363Feng LH, Sun HC, Zhu XD, Liu XF, Zhang SZ, Li XL, Li Y, Tang ZY. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy. Eur J Surg Oncol. 2021 Mar;47(3 Pt B):681-689. doi: 10.1016/j.ejso.2020.10.039. Epub 2020 Oct 31.
PubMed 33189491Ahmad T, Chavhan GB, Avitzur Y, Moineddin R, Oudjhane K. Doppler Parameters of the Hepatic Artery as Predictors of Graft Status in Pediatric Liver Transplantation. AJR Am J Roentgenol. 2017 Sep;209(3):671-675. doi: 10.2214/AJR.17.17902. Epub 2017 Jun 28.
PubMed 28657844Asthana S, McClean P, Stringer MD. Does the pediatric end-stage liver disease score or hepatic artery resistance index predict outcome after liver transplantation for biliary atresia? Pediatr Surg Int. 2006 Sep;22(9):697-700. doi: 10.1007/s00383-006-1737-1. Epub 2006 Aug 1.
PubMed 16896815Perrakis A, Fortsch T, Niebling N, Croner RS, Nissler V, Yedibela S, Lohmuller C, Zopf S, Kammerer F, Hohenberger W, Muller V. The diagnostic value of systolic acceleration time and resistive index as noninvasive modality for detection of graft rejection after orthotopic liver transplantation. Transplant Proc. 2013 Jun;45(5):1961-5. doi: 10.1016/j.transproceed.2013.01.058.
PubMed 23769083Magro B, Tacelli M, Mazzola A, Conti F, Celsa C. Biliary complications after liver transplantation: current perspectives and future strategies. Hepatobiliary Surg Nutr. 2021 Jan;10(1):76-92. doi: 10.21037/hbsn.2019.09.01.
PubMed 33575291
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Nomogram for Predicting Postoperative Early Biliary Complication in Adult Patients Following Liver Transplantation: a Retrospective Study
- ClinicalTrials.gov ID
- NCT06658665
- Acronym / sponsor ID
- NPBC / FAH-SYSU
- Conditions
- Liver Transplant Disorder
- Keywords
- liver transplantation, biliary complication, nomogram, prediction model
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 900 participants (estimated)
- Lead sponsor
- Sun Yat-sen UniversityUniversity, hospital or other
- Study start
- 1 Nov 2024 (estimated)
- Primary completion
- 15 Nov 2024 (estimated)
- Study completion
- 30 Dec 2024 (estimated)
- First posted
- 26 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to develop a nomogram model to predict biliary complications within 90 days in adult patients after liver transplantation. The main questions it aims to answer are:
Can the nomogram predict biliary complications within 90 days in adult patients after liver transplantation? What about the performance of the nomogram? Researchers will compare patients' preoperative variables, intraoperative factors, and postoperative outcomes to see what factors are associated with biliary complications.Subsequently, multivariable logistic regression analysis was conducted to evaluate the factors associated with biliary complications occurring within 90 days post-liver transplantation. Finally, a nomogram was developed.
Detailed description
Background: Liver transplantation (LT) is a critical therapeutic intervention for patients with end-stage liver disease or acute liver failure, offering favorable outcomes with survival rates of 76-90% at 1 year and approximately 70% at 5 years . Despite significant advancements in surgical techniques, immunosuppressive protocols, and organ preservation, biliary complications (BCs) remain a substantial cause of morbidity and mortality, frequently necessitating long-term interventions such as endoscopic, percutaneous, or surgical procedures. The incidence of BCs post-LT is estimated to range from 5% to 20%, with most occurring within the first three months postoperatively, although some may present years after LT . Among BCs, the most common are anastomotic strictures (AS), non-anastomotic strictures (NAS), and bile leaks. Treatment approaches include endoscopic techniques, percutaneous transhepatic biliary drainage, and surgical interventions. NAS and bile leaks typically manifest within the first year post-transplant but may arise later, with bile leaks occurring immediately or within weeks following surgery . Early postoperative monitoring and timely management are essential to preventing and addressing these complications.
In adult liver transplantation, several factors contribute to bile duct complications, including biliary ischemia, surgical techniques, infections, and donor characteristics . Among these, insufficient arterial blood supply to the bile ducts is recognized as a key factor likely contributing to the development of biliary complications. Unlike the liver parenchyma, which receives blood from both the portal vein and hepatic artery, the bile ducts depend solely on arterial blood flow. About 60% of the common bile duct's blood comes from the gastroduodenal artery, with the remaining 30-40% from hepatic artery branches. After liver transplantation, blood flow from the gastroduodenal artery is often disrupted, making the hepatic artery's role in supplying the distal bile duct even more critical. This reduced arterial support highlights the significance of maintaining adequate hepatic artery perfusion to prevent bile duct complications.
Ultrasound is essential for monitoring post-liver transplantation biliary complications, providing detailed imaging for early detection of issues like strictures and leaks. Parameters such as arterial resistive index (ARI) and flow velocity are critical for assessing hepatic artery condition and blood supply post-transplantation, offering insights into graft perfusion and viability. These non-invasive metrics are crucial for evaluating hepatic arterial circulation, may provide effective postoperative care and improving patient outcomes.
After liver transplantation, biliary complications most commonly occur during the early postoperative period, particularly within the first three months. More than half of all biliary complications are early complications occurring at the anastomotic site. Hence, early monitoring and intervention are crucial to promptly detect and manage these potential complications, thereby improving patient prognosis and survival rates in clinical settings. However, there is limited research on the risk factors and predict model for 90 days biliary complications after adult liver transplantation. Nomogram is a simple visual graph of statistical prediction model with an easy-to-use graphical interface. Importantly, it could generate personalized predictions, thereby, widely used in risk stratification and personally providing approach to disease management. This study aimed to establish a nomogram model to evaluate patients who underwent LT to help clinicians predict the risk of 90 days biliary complications and provide a more personalized treatment strategy.
Method Patients Data from patients who underwent OLT between 1 January 2016 to 31 December 2021 at the First Affiliated Hospital of Sun Yat-sen University were retrospectively extracted from the electronic medical record system. Exclusion criteria included age <18 years old, multiple organ transplantation, retransplantation, died intraoperatively or within 3 months after LT, and cases with missing important data or over 20% of data missing. Finally, a total of 757 patients were enrolled. This research study was reviewed and approved by the Ethics Committee at Hospital, waiving the requirement for informed consent in alignment with the Declaration of Helsinki. All operations were performed in accordance with the standard procedures by experienced surgical groups in our department.
Study protocol The work was approved by the Ethics Committee and registered on Clinicaltrial.gov. It was conducted and reported in line with the strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) criteria.
Difinition of biliary complications Biliary complications were suspected when patients exhibited fever, jaundice, or pale stools, or when lab results showed elevated conjugated bilirubin, gamma-glutamyltransferase, or alanine aminotransferase, with or without intrahepatic duct dilation on ultrasound. The diagnosis was primarily based on ultrasound findings and confirmed through Magnetic Resonance Cholangiopancreatography (MRCP) or endoscopic retrograde cholangiopancreatography (ERCP). Anastomotic strictures were defined as those within 1 cm of the surgical anastomosis, while non-anastomotic strictures were located at least 1 cm beyond it. Bile leakage was defined as the unintended escape of bile, confirmed by contrast extravasation during MRCP or ERCP.
Data collection and potential predictors Preoperative recipient variables included sex, age, height, weight, BMI, comorbidities (hypertension or diabetes mellitus), etiology of liver disease (viral hepatitis, malignancy, hepatic failure, cirrhosis, alcohol-related liver disease, and others), MELD score, Child-Pugh grade, and preoperative lab values (routine blood tests, coagulation markers, electrolytes, and biochemistry). Donor variables included sex, age, height, weight, BMI, type of donation, HBV infection status, and preoperative lab results. Intraoperative factors involved surgical technique , and specific biliary events (choledochojejunostomy or biliary stenting). Postoperative outcomes included arterial resistive index within 24 hours, transaminase levels, International Normalized Ratio, and ICU stay duration.
Logistic regression analysis and nomogram model development A total of 757 patients were randomly allocated into training and validation sets in a 7:3 ratio. To identify potential predictive factors, LASSO regression analysis was applied to the training set. This method effectively removed several irrelevant and multicollinear independent variables, thereby simplifying the high-dimensional data[. Subsequently, multivariable logistic regression analysis was conducted to evaluate the factors associated with biliary complications occurring within 90 days post-liver transplantation. Finally, a nomogram was developed from the training set and validated using the validation set.
Apparent performance of the nomogram Discrimination and calibration were utilized to evaluate the predictive accuracy of the developed model. Harrell's concordance index (C-index) and the receiver operating characteristic (ROC) curve (AUC) were calculated to assess the nomogram's discrimination capability. A C-index approaching 1 suggests a strong predictive ability of the model, while an AUC exceeding 0.80 indicates good discrimination. Furthermore, decision curve analysis (DCA) was conducted to examine the clinical applicability of the nomograms [Reporting and interpreting decision curve analysis: a guide for investigators.]. Both discrimination and calibration were evaluated using bootstrapping with 1000 resamples.
Statistical analysis: Continuous variables were not normally distributed according to the Kolmogorov-Smirnov test and were therefore analyzed using the Mann-Whitney U-test and presented as median (interquartile range). Categorical variables were compared using the χ2-test or Fisher's exact test and presented as absolute numbers (percentage). Statistical analysis was performed using R Software v.4.0.2 (The R Project for Statistical Computing, www.r-project. org) with the 'rms' package utilized for logistic regression analysis and nomogram construction. A two-sided P-value less than 0.05 was considered statistically significant.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| No biliary complication group | – | –The liver transplant patients who did not experience biliary complications within 90 days post-operation. |
| biliary complication group | – | –The liver transplant patients who experience biliary complications within 90 days post-operation. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Retrospective collection of cases of patients who underwent liver transplantation in the Organ Transplantation Department at Sun Yat-sen University First Affiliated Hospital between January 1, 2016, and December 31, 2021.
Key inclusion criteria (2 listed)
- ①Patients aged ≥ 18 years.
- ②Patients who underwent their first liver transplantation at Sun Yat-sen University First Affiliated Hospital between January 1, 2016, and December 31, 2021.
Key exclusion criteria (3 listed)
- Living donor liver transplantation. ② Split liver transplantation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Body Mass Index (BMI):
Time frame: 1-2 days before surgery
Calculated as weight (kg) / height (m²).
Surgical Technique
Time frame: Intraoperative time
Type of technique used (orthotopic, piggyback, or ischemia-free liver transplantation).
Weight
Time frame: 1-2 days before surgery
Measured in kilograms.
Height
Time frame: 1-2 days before surgery
Measured in meters.
Blood Loss
Time frame: 1-2 days before surgery
Measured in milliliters (mL).
Cold Ischemic Time
Time frame: intraoperative time
Measured in minutes.
Warm Ischemic Time
Time frame: intraoperative time
Measured in minutes.
2 secondary outcomes
Transaminase Levels
Time frame: 24 hours post-surgery.
ICU Stay Duration
Time frame: 24 hours post-surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2024.
- Background: PubMed 33855363Tingle SJ, Thompson ER, Ali SS, Figueiredo R, Hudson M, Sen G, White SA, Manas DM, Wilson CH. Risk factors and impact of early anastomotic biliary complications after liver transplantation: UK registry analysis. BJS Open. 2021 Mar 5;5(2):zrab019. doi: 10.1093/bjsopen/zrab019.
- Background: PubMed 33189491Feng LH, Sun HC, Zhu XD, Liu XF, Zhang SZ, Li XL, Li Y, Tang ZY. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy. Eur J Surg Oncol. 2021 Mar;47(3 Pt B):681-689. doi: 10.1016/j.ejso.2020.10.039. Epub 2020 Oct 31.
- Background: PubMed 28657844Ahmad T, Chavhan GB, Avitzur Y, Moineddin R, Oudjhane K. Doppler Parameters of the Hepatic Artery as Predictors of Graft Status in Pediatric Liver Transplantation. AJR Am J Roentgenol. 2017 Sep;209(3):671-675. doi: 10.2214/AJR.17.17902. Epub 2017 Jun 28.
- Background: PubMed 16896815Asthana S, McClean P, Stringer MD. Does the pediatric end-stage liver disease score or hepatic artery resistance index predict outcome after liver transplantation for biliary atresia? Pediatr Surg Int. 2006 Sep;22(9):697-700. doi: 10.1007/s00383-006-1737-1. Epub 2006 Aug 1.
- Background: PubMed 23769083Perrakis A, Fortsch T, Niebling N, Croner RS, Nissler V, Yedibela S, Lohmuller C, Zopf S, Kammerer F, Hohenberger W, Muller V. The diagnostic value of systolic acceleration time and resistive index as noninvasive modality for detection of graft rejection after orthotopic liver transplantation. Transplant Proc. 2013 Jun;45(5):1961-5. doi: 10.1016/j.transproceed.2013.01.058.
- Background: PubMed 33575291Magro B, Tacelli M, Mazzola A, Conti F, Celsa C. Biliary complications after liver transplantation: current perspectives and future strategies. Hepatobiliary Surg Nutr. 2021 Jan;10(1):76-92. doi: 10.21037/hbsn.2019.09.01.
- Individual participant dataSharing planned: Yes. The data sets used and/or analyzed for the present study are available from the corresponding author on reasonable request.
Related trials for Liver Transplant Disorder
Not yet recruitingPhase 1/2
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
Chronic Hepatitis B
RecruitingObservational study
Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation
Exocrine Pancreatic Insuficiency
Not yet recruitingObservational study
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
Hematopoietic Stem Cell Transplant
Active, not recruitingObservational study
AI-SC Multi-center Study
Liver Cirrhosis
Not yet recruitingObservational study
Prospective Observational Multimodal Neuromonitoring During High-Risk Adult Surgery
Postoperative Cognitive Complications, Delirium
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Liver Transplant Disorder, run by Sun Yat-sen University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 26 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Zepeng Lin (+86 13421560359, 13421560359@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body Mass Index (BMI): (time frame: 1-2 days before surgery). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06658665, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2024.